NO870408L - Fremgangsmaate for fremstilling av 2-amino-3-formyl-furaner - Google Patents

Fremgangsmaate for fremstilling av 2-amino-3-formyl-furaner

Info

Publication number
NO870408L
NO870408L NO870408A NO870408A NO870408L NO 870408 L NO870408 L NO 870408L NO 870408 A NO870408 A NO 870408A NO 870408 A NO870408 A NO 870408A NO 870408 L NO870408 L NO 870408L
Authority
NO
Norway
Prior art keywords
furanes
amino
preparing
procedure
formula
Prior art date
Application number
NO870408A
Other languages
English (en)
Norwegian (no)
Other versions
NO870408D0 (no
Inventor
Walter Losel
Otto Roos
Gerd Schnorrenberg
Dietrich Arndts
Franz-Josef Kuhn
Erich Lehr
Richard Reichl
Gunter Schingnitz
Georg Speck
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO870408D0 publication Critical patent/NO870408D0/no
Publication of NO870408L publication Critical patent/NO870408L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
NO870408A 1986-02-03 1987-02-02 Fremgangsmaate for fremstilling av 2-amino-3-formyl-furaner NO870408L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863603194 DE3603194A1 (de) 1986-02-03 1986-02-03 Neue 2-amino-3-formyl-furane, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen

Publications (2)

Publication Number Publication Date
NO870408D0 NO870408D0 (no) 1987-02-02
NO870408L true NO870408L (no) 1987-08-04

Family

ID=6293224

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870408A NO870408L (no) 1986-02-03 1987-02-02 Fremgangsmaate for fremstilling av 2-amino-3-formyl-furaner

Country Status (16)

Country Link
EP (1) EP0234329A1 (fi)
JP (1) JPS62185086A (fi)
KR (1) KR870007922A (fi)
AU (1) AU6823587A (fi)
CS (1) CS67287A2 (fi)
DD (1) DD260067A5 (fi)
DE (1) DE3603194A1 (fi)
DK (1) DK52687A (fi)
FI (1) FI870435A (fi)
HU (1) HU900157D0 (fi)
IL (1) IL81447A0 (fi)
NO (1) NO870408L (fi)
PL (1) PL263934A1 (fi)
PT (1) PT84240B (fi)
YU (1) YU13787A (fi)
ZA (1) ZA87730B (fi)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3143876A1 (de) * 1981-11-05 1983-05-11 Boehringer Ingelheim KG, 6507 Ingelheim Neue1-furyl-3,4-dihydroisochinoline diese enthaltende arzneimittel sowie verfahren zu deren herstellung und deren verwendung
DE3401018A1 (de) * 1984-01-13 1985-07-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung von 5,6-dihydro-pyrrolo(2,1-a)isochinolinen

Also Published As

Publication number Publication date
PL263934A1 (en) 1988-07-21
JPS62185086A (ja) 1987-08-13
IL81447A0 (en) 1987-09-16
NO870408D0 (no) 1987-02-02
YU13787A (en) 1988-10-31
PT84240B (pt) 1991-02-08
EP0234329A1 (de) 1987-09-02
DK52687D0 (da) 1987-02-02
ZA87730B (en) 1988-10-26
PT84240A (de) 1987-03-01
DE3603194A1 (de) 1987-08-06
FI870435A0 (fi) 1987-02-02
HU900157D0 (en) 1990-03-28
KR870007922A (ko) 1987-09-22
CS67287A2 (en) 1990-10-12
DD260067A5 (de) 1988-09-14
FI870435A (fi) 1987-08-04
AU6823587A (en) 1987-08-06
HUT47100A (en) 1989-01-30
DK52687A (da) 1987-08-04

Similar Documents

Publication Publication Date Title
NO850300L (no) Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater
DK263587A (da) Imidazoquinolinyletherderivater
DK82087D0 (da) Pyrocatecholderivater
DK69887A (da) Dichloranilinderivater
ATA312487A (de) Tetrahydrocarbazolonderivate
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO172447C (no) Fremgangsmaate for fremstilling av b-avermectiner
DK388887A (da) Substituerede amider
DK693587D0 (da) Alkansulfonanilidderivater
DK81888D0 (da) Dibenzoxepinderivater
DK691287D0 (da) 5-floururacilderivater
DK210487A (da) Substituerede benzimidazolderivater
NO171910C (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler
TR24926A (tr) Diflufenikan kullanan herbisidal usul
DK444687A (da) Alfa-substituerede ketonitron-derivater
ES551481A0 (es) Procedimiento de preparar derivados iminotiazolidinicos
NO851550L (no) Fremgangsmaate for fremstilling av imidazolderivater
DK229887A (da) Alkenamidderivater
DK440687A (da) Bicyclooctanderivater
DK619187A (da) Isoindolderivater
NO870828L (no) FremgangsmŸte for fremstilling av biskarbamater.
DK329787A (da) Fremgangsmaade til fremstilling af mercaptoacylprolinderivater
NO172095C (no) Framgangsmaate for framstilling av sondenaering
DK435087A (da) Isoprenderivater
NO874958D0 (no) Fremgangsmaate for fremstilling av 1-aryloksy-3-amino-2-propanoler.